Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Use of pembrolizumab among older adults with cancer in the United States, before and after FDA approval of its tumor‐agnostic indication

Pharmacoepidemiology and Drug Safety(2023)10.1002/pds.5745Source: DataRank Database

Use of pembrolizumab among older adults with cancer in the United States, before and after FDA approval of its tumor‐agnostic indication is a research paper published in Pharmacoepidemiology and Drug Safety (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: greenTopics (30)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Lindsey Enewold ORCID,Michael T. Halpern ORCID,Chris Zeruto,Angela B. Mariotto ORCID,Yoon Duk Hong ORCID

Live enrichment

PubMed:38156547 PMC:PMC10842934

Intramural NIH HHS

Grant: Z99 CA999999

greenLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10842934/pdf/nihms-1951931.pdf

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5745

Fields of Study

HumansAgedUnited StatesAdultMiddle AgedUnited States Food and Drug AdministrationMedicareAntibodies, Monoclonal, HumanizedAntineoplastic AgentsBrain NeoplasmsDrug ApprovalNeoplastic Syndromes, HereditaryColorectal NeoplasmsTurcot syndrome

MeSH Terms

HumansColorectal NeoplasmsBrain NeoplasmsNeoplastic Syndromes, HereditaryAntineoplastic AgentsDrug ApprovalUnited States Food and Drug AdministrationAdultAgedMiddle AgedMedicareUnited StatesAntibodies, Monoclonal, Humanized

Keywords

ImmunotherapyReal-world DataTumor-agnostic Therapy